Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nesprin-1 (spectrin repeat containing nuclear envelope protein 1) is a giant, multi-isomeric protein located primarily at the outer nuclear membrane, functioning as a scaffolding and structural link between the cytoskeleton and the nuclear envelope. It is a component of the LINC complex, which coordinates nuclear positioning, integrity, and mechanical signaling. Nesprin-1 is ubiquitously expressed, with various tissue-specific isoforms generated via alternative splicing. Mutations in the SYNE1 gene are associated with autosomal recessive cerebellar ataxia and muscular dystrophies, with increasing evidence for distinct roles in muscle and neuronal function. Research suggests isoform-specific disruption may contribute to disease phenotypes such as nuclear mispositioning and altered cell morphology. As of now, Nesprin-1 is not a direct pharmacological or therapeutic target, but it is important in understanding the molecular basis of several inherited diseases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spectrin repeat containing nuclear envelope protein 1 (Nesprin-1 (also SYNE1)).